Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Alkem Laboratories Ltd. ( (IN:ALKEM) ) has provided an announcement.
Alkem Laboratories has received a Certificate of GMP Compliance of a Manufacturer from the Malta Medicines Authority for its manufacturing facility in Daman, India. The EU-aligned certification, valid for three years from the December 9, 2025 inspection date, enhances Alkem’s regulatory credentials in Europe and is expected to strengthen its ability to supply medicines to EU markets and support its international growth strategy.
The company disclosed the receipt of this certificate under SEBI listing regulations and will publish the disclosure on its website for investor transparency. The recognition of GMP compliance at the Daman plant reinforces Alkem’s quality standards and could bolster stakeholder confidence in its manufacturing capabilities and export potential.
More about Alkem Laboratories Ltd.
Alkem Laboratories Ltd. is an India-based pharmaceutical company engaged in the development, manufacturing, and marketing of generic and branded formulations. The company operates multiple manufacturing facilities serving domestic and international markets, with a focus on regulated regions such as the European Union.
Average Trading Volume: 21,667
Technical Sentiment Signal: Hold
Current Market Cap: 626.6B INR
For a thorough assessment of ALKEM stock, go to TipRanks’ Stock Analysis page.